Status:
COMPLETED
Use of the MiCK Assay for Apoptosis in AML
Lead Sponsor:
Pierian Biosciences
Collaborating Sponsors:
DiaTech Oncology and Vanderbilt University
Conditions:
Leukemia, Myelocytic, Acute
Eligibility:
All Genders
18+ years
Brief Summary
A previous preliminary study performed at Vanderbilt University with funding from the Leukemia Society of America demonstrated that the response of leukemia cells in vitro to the chemotherapeutic agen...
Detailed Description
A previous preliminary study performed at Vanderbilt University with funding from the Leukemia Society of America demonstrated that the response of leukemia cells in vitro to the chemotherapeutic agen...
Eligibility Criteria
Inclusion
- patients with newly diagnosed acute myeloid leukemia (AML
Exclusion
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00286845
Start Date
January 1 2006
End Date
December 1 2009
Last Update
January 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center and DiaTech Oncology
Nashville, Tennessee, United States, 37212